Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD
about
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Wnt2b attenuates HSCs activation and liver fibrosis through negative regulating TLR4 signaling.High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.Reelin expression in human liver of patients with chronic hepatitis C infection.Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Starring role of toll-like receptor-4 activation in the gut-liver axis.Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis.Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling.Association between endotoxemia and histological features of nonalcoholic fatty liver diseaseSignalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4.Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH).Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation.The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention.European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts
P2860
Q33719929-03A1090E-3BED-4D57-9713-964242AC12F3Q33822409-00DCFFE7-7D68-4A7B-A4ED-86884F0CBE69Q36255749-69598930-4EA9-489C-9FDF-43A9CD1DBFFDQ36333189-24DCB5CA-BB1D-4B94-AECF-0B9EE7FFF686Q37720268-0F07FD4B-2460-471C-BC5E-75531464D6DAQ38303313-A6E690D8-C8CD-42D7-A883-64998AAAB2E5Q38645789-C189FEAB-DDD1-4C6D-B11E-D2DCA703B6DDQ39038603-9AEAD4F4-572C-423E-9561-DF237878F401Q39363389-A5006898-A867-4956-B515-40B12E57E813Q39790741-D046478B-AD20-49ED-BDFA-FD8BCABB52D9Q40176500-B015AF46-477C-49CE-B83C-A86F1504873FQ40326054-660EF220-563D-4993-894C-9F7B2A0B3A52Q40946732-FC2AE570-722A-4326-94DC-0E8CB190E359Q50884722-2FC5EF9D-E9A2-4D86-A008-07DB9705F7B1Q51281926-07045852-9729-44F7-AE82-CAF6DA872B40Q52877979-F02728B0-823B-473E-9E60-ABE0FDE574A4Q53447872-C01883F6-BC46-4650-B20B-E77B240DEAB0Q53681665-46067D66-B916-43F9-AC7A-64A8F463AB05Q57687713-487C63C5-4347-4504-86AF-21B04A8C7F79
P2860
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD
description
im April 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 April 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2014
@uk
name
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@en
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@nl
type
label
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@en
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@nl
prefLabel
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@en
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@nl
P2860
P50
P356
P1433
P1476
Hepatic toll-like receptor 4 e ...... ibrosis in patients with NAFLD
@en
P2093
Chiara Mazzarelli
Giovanni Galati
P2860
P304
P356
10.1111/LIV.12531
P50
P577
2014-04-05T00:00:00Z